Summary
This 8-K filing from CVS Health on June 6, 2018, primarily announces the departure of Executive Vice President and Chief Financial Officer, David M. Denton, effective upon the closing of the Aetna acquisition or December 31, 2018, whichever comes first. Mr. Denton will receive a severance package including 24 months of continued base salary and subsidized benefits, along with pro-rated bonus and continued vesting for certain equity awards, contingent on meeting employment obligations and non-compete clauses. The filing also provides an update on the Aetna acquisition, reiterating that the transaction remains on track for a second-half 2018 closing, subject to regulatory approvals. Additionally, CVS Health announced its proposed senior management team expected to be in place post-acquisition. Compensation details for these new appointees are yet to be determined and will be finalized at the time of closing.
Key Highlights
- 1David M. Denton, EVP and CFO, is departing CVS Health.
- 2Denton's departure is tied to the closing of the Aetna acquisition or December 31, 2018.
- 3Denton to receive 24 months of continued base salary and subsidized benefits as severance.
- 4Severance package includes pro-rated 2018 bonus and continued vesting of some equity awards.
- 5Denton must remain employed through the Aetna acquisition closing or year-end to receive severance.
- 6Aetna acquisition remains on track for H2 2018 closing, pending regulatory approvals.
- 7CVS Health announced its proposed senior management team for post-Aetna acquisition.